{"pageContent": "Background: Pretreatment urinary, bowel, and sexual dysfunction may increase the toxicity of prostate cancer treatments or preclude potential benefits. Using patient-reported baseline dysfunction from a prospective cohort study, we determined the proportion of patients receiving relatively contraindicated ('mismatched') treatments.", "metaData": {"source": "Prostate cancer: extended pelvic lymph node removal--extended survival\nhttps://pubmed.ncbi.nlm.nih.gov/24934448/"}}